WO1999038973A3 - Compounds for therapy and diagnosis of lung cancer and methods for their use - Google Patents
Compounds for therapy and diagnosis of lung cancer and methods for their use Download PDFInfo
- Publication number
- WO1999038973A3 WO1999038973A3 PCT/US1999/001642 US9901642W WO9938973A3 WO 1999038973 A3 WO1999038973 A3 WO 1999038973A3 US 9901642 W US9901642 W US 9901642W WO 9938973 A3 WO9938973 A3 WO 9938973A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lung cancer
- compounds
- methods
- diagnosis
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IDW20001646A ID27813A (en) | 1998-01-28 | 1999-01-20 | COMPOUNDS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER AND METHODS FOR USE |
IL13741799A IL137417A0 (en) | 1998-01-28 | 1999-01-26 | Polypeptides containing at least a portion of a lung tumor protien and pharmaceutical compositions containing the same |
BR9907259-9A BR9907259A (en) | 1998-01-28 | 1999-01-26 | Compounds for therapy and diagnosis of lung cancer and processes for their use |
JP2000529432A JP2002516659A (en) | 1998-01-28 | 1999-01-26 | Compounds for the treatment and diagnosis of lung cancer and methods of using them |
KR1020007008209A KR20010034436A (en) | 1998-01-28 | 1999-01-26 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
CA002319117A CA2319117A1 (en) | 1998-01-28 | 1999-01-26 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
EP99903417A EP1051489A2 (en) | 1998-01-28 | 1999-01-26 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
AU23443/99A AU2344399A (en) | 1998-01-28 | 1999-01-26 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
ZA9900693A ZA99693B (en) | 1998-01-28 | 1999-01-28 | Compounds for therapy and diagnosis of lung cancer and methods for their use. |
NO20003853A NO20003853L (en) | 1998-01-28 | 2000-07-27 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1502298A | 1998-01-28 | 1998-01-28 | |
US1502998A | 1998-01-28 | 1998-01-28 | |
US09/015,022 | 1998-01-28 | ||
US09/015,029 | 1998-01-28 | ||
US4082898A | 1998-03-18 | 1998-03-18 | |
US4083198A | 1998-03-18 | 1998-03-18 | |
US09/040,828 | 1998-03-18 | ||
US09/040,831 | 1998-03-18 | ||
US12219298A | 1998-07-23 | 1998-07-23 | |
US12219198A | 1998-07-23 | 1998-07-23 | |
US09/122,191 | 1998-07-23 | ||
US09/122,192 | 1998-07-23 | ||
US21924598A | 1998-12-22 | 1998-12-22 | |
US09/219,245 | 1998-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999038973A2 WO1999038973A2 (en) | 1999-08-05 |
WO1999038973A3 true WO1999038973A3 (en) | 1999-12-09 |
Family
ID=27567530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/001642 WO1999038973A2 (en) | 1998-01-28 | 1999-01-26 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1051489A2 (en) |
JP (1) | JP2002516659A (en) |
KR (1) | KR20010034436A (en) |
CN (1) | CN1292029A (en) |
AR (1) | AR014514A1 (en) |
AU (1) | AU2344399A (en) |
BR (1) | BR9907259A (en) |
CA (1) | CA2319117A1 (en) |
ID (1) | ID27813A (en) |
IL (1) | IL137417A0 (en) |
NO (1) | NO20003853L (en) |
WO (1) | WO1999038973A2 (en) |
ZA (1) | ZA99693B (en) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6737514B1 (en) | 1998-12-22 | 2004-05-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
US6312695B1 (en) | 1998-03-18 | 2001-11-06 | Corixa Corporation | Compounds and methods for therapy of lung cancer |
US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6660838B1 (en) | 1998-03-18 | 2003-12-09 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6531315B1 (en) | 1998-03-18 | 2003-03-11 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US7049063B2 (en) | 1998-03-18 | 2006-05-23 | Corixa Corporation | Methods for diagnosis of lung cancer |
US6518256B1 (en) | 1998-03-18 | 2003-02-11 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6696247B2 (en) | 1998-03-18 | 2004-02-24 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6482597B1 (en) | 1999-12-17 | 2002-11-19 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6821518B1 (en) | 1998-03-18 | 2004-11-23 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6426072B1 (en) | 2000-08-02 | 2002-07-30 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
EP0987552A3 (en) | 1998-08-31 | 2000-06-07 | Pfizer Products Inc. | Diarylsulfonylurea binding proteins |
EP1526383A3 (en) * | 1998-08-31 | 2005-11-16 | Pfizer Products Inc. | Diarylsulfonylurea binding proteins |
CA2348733A1 (en) * | 1998-10-28 | 2000-05-11 | Rigel Pharmaceuticals, Inc. | Novel compositions and methods of screening for t-cell and b-cell activation modulators |
US6709855B1 (en) | 1998-12-18 | 2004-03-23 | Scios, Inc. | Methods for detection and use of differentially expressed genes in disease states |
AU2055300A (en) * | 1998-12-18 | 2000-07-03 | Scios Inc. | Methods for detection and use of differentially expressed genes in disease states |
WO2000046370A1 (en) * | 1999-02-04 | 2000-08-10 | Board Of Trustees Of The University Of Illinois | P37ing1 compositions and methods of use |
US6544946B1 (en) | 1999-02-19 | 2003-04-08 | Zymogenetics, Inc. | Inhibitors for use in hemostasis and immune function |
CZ20012916A3 (en) | 1999-02-19 | 2002-05-15 | Zymogenetics, Inc. | Pharmaceutical preparation |
WO2000060077A2 (en) * | 1999-04-02 | 2000-10-12 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
ES2308976T3 (en) * | 1999-04-02 | 2008-12-16 | Corixa Corporation | COMPOUNDS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF CANCER DE PULMON. |
US6759508B2 (en) | 2000-09-01 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6444425B1 (en) | 1999-04-02 | 2002-09-03 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
US6914132B1 (en) | 1999-06-30 | 2005-07-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6746846B1 (en) | 1999-06-30 | 2004-06-08 | Corixa Corporation | Methods for diagnosing lung cancer |
US6858204B2 (en) | 1999-06-30 | 2005-02-22 | Corxia Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20030211510A1 (en) | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6504010B1 (en) | 1999-06-30 | 2003-01-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20030125245A1 (en) | 1999-06-30 | 2003-07-03 | Tongtong Wang | Compositions and methods for therapy and diagnosis of lung cancer |
US6509448B2 (en) | 1999-06-30 | 2003-01-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6686447B1 (en) | 1999-06-30 | 2004-02-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6667154B1 (en) | 1999-06-30 | 2003-12-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
HUP0201757A3 (en) | 1999-06-30 | 2010-01-28 | Corixa Corp | Compositoins and methods for the therapy and diagnosis of lung cancer |
CA2309313A1 (en) * | 1999-08-05 | 2001-02-05 | Board Of Trustees Of The University Of Arkansas | Stimulation of the immune response by human dendritic cell manipulation |
AU7832700A (en) * | 1999-09-23 | 2001-04-24 | Corixa Corporation | Ovarian tumor antigen and methods of use therefor |
CA2491610A1 (en) * | 1999-12-01 | 2001-06-07 | Kevin P. Baker | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
JP2004518401A (en) * | 2000-04-14 | 2004-06-24 | インサイト・ゲノミックス・インコーポレイテッド | Molecules related to human reproduction |
US20020099012A1 (en) * | 2000-06-29 | 2002-07-25 | Tongtong Wang | Compositions and methods for the therapy and diagnosis of lung cancer |
EP1343886A2 (en) * | 2000-07-11 | 2003-09-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
AU2001270638A1 (en) * | 2000-07-19 | 2002-01-30 | Bayer Aktiengesellschaft | Regulation of human airway trypsin protease-like enzyme |
EP1314779B1 (en) * | 2000-08-28 | 2007-10-03 | Teijin Limited | Airway-specific trypsin-like enzymes and method of using the same |
AU2002249521B2 (en) | 2001-01-16 | 2007-06-21 | Serono Genetics Institute S.A. | Discriminative nucleic acid analysis using clone sequence signatures |
GB0101300D0 (en) * | 2001-01-18 | 2001-02-28 | Univ Cambridge Tech | Primordial germ cell genes |
US7226994B2 (en) | 2001-01-18 | 2007-06-05 | Cambridge University Technical Services Limited | Cell surface expressed marker of pluripotency |
JP2005505258A (en) | 2001-06-21 | 2005-02-24 | イシス・イノベイション・リミテッド | ANGE gene in atopy |
AU2007216892B2 (en) * | 2002-08-16 | 2011-02-10 | Agensys, Inc. | Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer |
US20040081653A1 (en) * | 2002-08-16 | 2004-04-29 | Raitano Arthur B. | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
AU2003296330A1 (en) * | 2002-12-10 | 2004-06-30 | Epimmune Inc. | Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions |
BRPI0518734A2 (en) * | 2004-11-30 | 2008-12-02 | Veridex Llc | prognosis of lung cancer |
CA2900087C (en) | 2005-10-17 | 2024-02-13 | Sloan Kettering Institute For Cancer Research | Wt1 hla class ii-binding peptides and compositions and methods comprising same |
PL2010209T3 (en) | 2006-04-10 | 2017-04-28 | Sloan Kettering Inst For Cancer Res | Immunogenic wt-1 peptides and methods of use thereof |
JP2010501172A (en) * | 2006-08-25 | 2010-01-21 | オンコセラピー・サイエンス株式会社 | Prognostic markers and therapeutic targets for lung cancer |
EP2334826A4 (en) * | 2008-09-12 | 2012-01-25 | Cancer Res Initiative Foundation | Method of detection and diagnosis of oral and nasopharyngeal cancers |
CN101891802B (en) * | 2009-08-11 | 2011-11-16 | 武汉凯泰新生物技术有限公司 | Polypeptide or derivative product for treating or preventing cancer and application thereof |
CN101921313B (en) * | 2010-04-07 | 2012-02-29 | 武汉凯泰新生物技术有限公司 | Polypeptide for curing or preventing cancer or derivative product and application thereof |
GB201104286D0 (en) * | 2011-03-15 | 2011-04-27 | Randox Lab Ltd | Glutathione S-transferase omega 1 wild type specific antibody |
CN103958679A (en) * | 2011-09-09 | 2014-07-30 | 转基因股份有限公司 | Antibody against mutant alpha-actinin-4 |
US20150104413A1 (en) | 2012-01-13 | 2015-04-16 | Memorial Sloan Kettering Cancer Center | Immunogenic wt-1 peptides and methods of use thereof |
ES2832546T3 (en) | 2013-01-15 | 2021-06-10 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 Peptides and Methods of Using Them |
US10815273B2 (en) | 2013-01-15 | 2020-10-27 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 peptides and methods of use thereof |
CN109476721B (en) * | 2016-04-04 | 2022-06-28 | 英蒂分子公司 | CD 8-specific capture agents, compositions and methods of use and preparation |
US11485760B2 (en) * | 2016-11-16 | 2022-11-01 | The Regents Of The University Of California | Inhibitors of CRISPR-Cas9 |
CN110669104B (en) * | 2019-10-30 | 2021-11-05 | 上海交通大学 | Group of markers derived from human peripheral blood mononuclear cells and application thereof |
CN112500467B (en) * | 2020-12-14 | 2022-05-24 | 上海交通大学 | Bioactive peptide RRECPSDECGAGVF, and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996002552A1 (en) * | 1994-07-19 | 1996-02-01 | Cytoclonal Pharmaceutics, Inc. | Lung cancer marker |
WO1996030389A1 (en) * | 1995-03-29 | 1996-10-03 | Millenium Pharmaceuticals, Inc. | Compositions for the diagnosis, prevention, and treatment of tumor progression |
-
1999
- 1999-01-20 ID IDW20001646A patent/ID27813A/en unknown
- 1999-01-26 BR BR9907259-9A patent/BR9907259A/en not_active Application Discontinuation
- 1999-01-26 EP EP99903417A patent/EP1051489A2/en not_active Withdrawn
- 1999-01-26 WO PCT/US1999/001642 patent/WO1999038973A2/en not_active Application Discontinuation
- 1999-01-26 AU AU23443/99A patent/AU2344399A/en not_active Abandoned
- 1999-01-26 CN CN99803446A patent/CN1292029A/en active Pending
- 1999-01-26 CA CA002319117A patent/CA2319117A1/en not_active Abandoned
- 1999-01-26 KR KR1020007008209A patent/KR20010034436A/en not_active Application Discontinuation
- 1999-01-26 IL IL13741799A patent/IL137417A0/en unknown
- 1999-01-26 JP JP2000529432A patent/JP2002516659A/en not_active Withdrawn
- 1999-01-28 ZA ZA9900693A patent/ZA99693B/en unknown
- 1999-01-28 AR ARP990100346A patent/AR014514A1/en unknown
-
2000
- 2000-07-27 NO NO20003853A patent/NO20003853L/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996002552A1 (en) * | 1994-07-19 | 1996-02-01 | Cytoclonal Pharmaceutics, Inc. | Lung cancer marker |
WO1996030389A1 (en) * | 1995-03-29 | 1996-10-03 | Millenium Pharmaceuticals, Inc. | Compositions for the diagnosis, prevention, and treatment of tumor progression |
Non-Patent Citations (2)
Title |
---|
CHEN S-L ET AL: "Isolation and characterizaton of a novel gene expressed in multiple cancers", ONCOGENE, vol. 12, no. 4, 15 February 1996 (1996-02-15), pages 741 - 751, XP002106655 * |
YOU L ET AL.: "Identification of early growth response gene-1 (Egr-1) as a phorbol myristate-induced gene in lung cancer cells by differential mRNA display", AM. J. RESPIR. CELL MOL. BIOL., vol. 17, no. 5, November 1997 (1997-11-01), pages 617 - 624, XP002106654 * |
Also Published As
Publication number | Publication date |
---|---|
EP1051489A2 (en) | 2000-11-15 |
IL137417A0 (en) | 2001-07-24 |
KR20010034436A (en) | 2001-04-25 |
NO20003853D0 (en) | 2000-07-27 |
CN1292029A (en) | 2001-04-18 |
JP2002516659A (en) | 2002-06-11 |
AR014514A1 (en) | 2001-02-28 |
ZA99693B (en) | 1999-10-21 |
WO1999038973A2 (en) | 1999-08-05 |
ID27813A (en) | 2001-04-26 |
NO20003853L (en) | 2000-09-27 |
CA2319117A1 (en) | 1999-08-05 |
BR9907259A (en) | 2002-01-22 |
AU2344399A (en) | 1999-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999038973A3 (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
WO1999047674A3 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
WO2000061612A3 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
WO1999033869A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
WO1998037093A3 (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
TW581808B (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
IL153996A0 (en) | Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same | |
WO1997025426A3 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
WO2000036107A3 (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
WO2000061756A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
WO1998045328A3 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
CA2234263A1 (en) | Pharmaceutical composition for treating papillomavirus tumours and infection | |
WO2001018046A3 (en) | Ovarian tumor sequences and methods of use therefor | |
IL152847A0 (en) | Polypeptides containing at least a portion of a breast tumor protein, polynucleotides encoding the same and diagnostic methods utilizing the same | |
WO1999037775A3 (en) | Compositions and methods for detecting and treating breast cancer | |
WO2004015390A3 (en) | Lung cancer target proteins and use thereof | |
EP1792988A3 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
AU2002228940A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
WO2001055391A3 (en) | 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer | |
WO1999054466A3 (en) | Colon cancer-associated antigens and their diagnostic and therapeutic uses | |
WO1999050289A3 (en) | Transformation progression-related genes and their use | |
WO1999037778A3 (en) | Compositions and methods for detecting and treating prostate cancer | |
CO5050254A1 (en) | COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF CANCER DE PULMON |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99803446.0 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 23443/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 137417 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2319117 Country of ref document: CA Ref document number: 2319117 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2000 529432 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020007008209 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/A/2000/007426 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999903417 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999903417 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020007008209 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020007008209 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999903417 Country of ref document: EP |